The fact that JAK3 deficient mice exhibit profound T cell impairment and JAK3 deficient patients exhibit severe combined immunodeficiency [72], [73] has led to an intense effort to identify inhibitors with specificity for JAK3 as unique immunosuppressive therapeutic agents. The gene discussed is JAK3; the disease is immune system disorder.